97 related articles for article (PubMed ID: 23352154)
1. How useful is carcinoembryonic antigen in detecting colorectal malignancy?
Buhagiar M; Ellul P
Eur J Intern Med; 2013 Jul; 24(5):480-1. PubMed ID: 23352154
[No Abstract] [Full Text] [Related]
2. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
[TBL] [Abstract][Full Text] [Related]
3. Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
Shimwell NJ; Wei W; Wilson S; Wakelam MJ; Ismail T; Iqbal T; Johnson PJ; Martin A; Ward DG
Cancer Biomark; 2010; 7(3):123-32. PubMed ID: 21263188
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoembryonic antigen].
Averbach M
Arq Gastroenterol; 1997; 34(1):1-2. PubMed ID: 9458952
[No Abstract] [Full Text] [Related]
5. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
Huber K; Kirchheimer JC; Sedlmayer A; Bell C; Ermler D; Binder BR
Cancer Res; 1993 Apr; 53(8):1788-93. PubMed ID: 8467497
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen monitoring for early detection of asymptomatic incurable metastatic colorectal cancer.
Rother M
J Clin Oncol; 2007 Apr; 25(10):1293-4; author reply 1294. PubMed ID: 17401025
[No Abstract] [Full Text] [Related]
7. CA 242--a step ahead.
Shahi SK; Ranga S; Bhullar C
Indian J Pathol Microbiol; 2002 Apr; 45(2):145-6. PubMed ID: 12696727
[No Abstract] [Full Text] [Related]
8. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
[TBL] [Abstract][Full Text] [Related]
10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
11. [After-care of colorectal carcinoma--value of tumor markers].
Köhne CH; Benter T
Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
[No Abstract] [Full Text] [Related]
12. [Acute-phase proteins in colorectal cancer].
Dumitraşcu D; Stanciu L; Radu D; Dejica D; Ban A; Ioniţă A; Petcovici M; Duca S; Cazacu M; Funaru G
Med Interna; 1992; 44(2-4):41-6. PubMed ID: 1285361
[No Abstract] [Full Text] [Related]
13. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
14. [Serum markers in breast cancer and colorectal cancer (1997)].
Bellet D; Mlika-Cabanne N; Bedenne L; Brun B; Demeaux JL; Legrand JL; Lorimier G; Mignotte H; Ollivier JM; Piperno-Neumann S; Rinaldi Y; Rousset H; Rymer JC; Laversin S
Gynecol Obstet Fertil; 2001 Jan; 29(1):62-3. PubMed ID: 11217195
[No Abstract] [Full Text] [Related]
15. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers at the preoperative examination and monitoring of surgical treatment of patients with colorectal cancer].
Bakhlaev IE; Fetiukov AI; Iastrebova AV; Romanov AA
Vestn Khir Im I I Grek; 2011; 170(5):19-22. PubMed ID: 22238958
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.
Taniguchi T; Makino M; Suzuki K; Kaibara N
Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326
[TBL] [Abstract][Full Text] [Related]
18. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.
Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258
[TBL] [Abstract][Full Text] [Related]
20. The effect of colonoscopy on tumor markers.
Scapa E; Broide E; Pinhasov I
Surg Laparosc Endosc; 1997 Dec; 7(6):477-9. PubMed ID: 9438630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]